Used in pharmaceutical research as a key intermediate in the synthesis of factor Xa inhibitors, which are anticoagulant drugs designed to prevent blood clot formation. It plays a role in developing treatments for cardiovascular diseases such as deep vein thrombosis, pulmonary embolism, and stroke. The compound's structure enables selective interaction with serine proteases, enhancing drug specificity and reducing bleeding risks compared to traditional anticoagulants. Also investigated for improved bioavailability and metabolic stability in oral dosage forms.